Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative engaged by the manufacturer and to pay an annual fee for each name listed with the department of business regulation.

Introduced

Feb 26, 2025

Last Action

Mar 6, 2025

Session

RI 2025

AI Summary

Get a plain-English explanation of what this bill does, who it affects, and why it matters.

03/06/2025 Committee recommended measure be held for further study

SB 710

Previous Bill

HB 5508

Next Bill

→

Talk to us

AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- THE PRESCRIPTION DRUG SALES REPRESENTATIVE DISCLOSURE ACT

AI Summary

Status

Primary Sponsors